HOME › DRUGS › IDARUCIZUMAB
ACTIVE SUBSTANCE / INN

IDARUCIZUMAB

Brand name(s): Praxbind, PRAXBIND
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761025
Hemorrhage
ACTIVE SUBSTANCE
Idarucizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Boehringer Ingelheim International GmbH, BOEHRINGER INGELHEIM
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PRAXBINDBLA761025BOEHRINGER INGELHEIMPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PraxbindBoehringer Ingelheim International GmbHAuthorised20/11/2015Hemorrhage

FULL INTELLIGENCE ON IDARUCIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →